These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 16380476)

  • 1. Coexpression of CD25 and OX40 (CD134) receptors delineates autoreactive T-cells in type 1 diabetes.
    Endl J; Rosinger S; Schwarz B; Friedrich SO; Rothe G; Karges W; Schlosser M; Eiermann T; Schendel DJ; Boehm BO
    Diabetes; 2006 Jan; 55(1):50-60. PubMed ID: 16380476
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD25 expression distinguishes functionally distinct alloreactive CD4 CD134 (OX40) T-cell subsets in acute graft-versus-host disease.
    Streeter PR; Zhang X; Tittle TV; Schön CN; Weinberg AD; Maziarz RT
    Biol Blood Marrow Transplant; 2004 May; 10(5):298-309. PubMed ID: 15111929
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD4+CD25+ T-cell populations expressing CD134 and GITR are associated with disease activity in patients with Wegener's granulomatosis.
    Wilde B; Dolff S; Cai X; Specker C; Becker J; Tötsch M; Costabel U; Dürig J; Kribben A; Tervaert JW; Schmid KW; Witzke O
    Nephrol Dial Transplant; 2009 Jan; 24(1):161-71. PubMed ID: 18723571
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autoreactive T cell response in CD25-negative fraction of peripheral blood mononuclear cells in established type 1 diabetes.
    Moriyama H; Kotani R; Katsuta A; Kameno M; Arai T; Okumachi Y; Kishi M; Yamada K; Yasuda H; Hara K; Yokono K; Nagata M
    Ann N Y Acad Sci; 2008 Dec; 1150():278-81. PubMed ID: 19120313
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation-associated phenotype of CD3 T cells in acute graft-versus-host disease.
    Paz Morante M; Briones J; Canto E; Sabzevari H; Martino R; Sierra J; Rodriguez-Sanchez JL; Vidal S
    Clin Exp Immunol; 2006 Jul; 145(1):36-43. PubMed ID: 16792671
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibodies to OX-40 (CD134) can identify and eliminate autoreactive T cells: implications for human autoimmune disease.
    Weinberg AD
    Mol Med Today; 1998 Feb; 4(2):76-83. PubMed ID: 9547794
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deficiency in NOD antigen-presenting cell function may be responsible for suboptimal CD4+CD25+ T-cell-mediated regulation and type 1 diabetes development in NOD mice.
    Alard P; Manirarora JN; Parnell SA; Hudkins JL; Clark SL; Kosiewicz MM
    Diabetes; 2006 Jul; 55(7):2098-105. PubMed ID: 16804081
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GAD65- and proinsulin-specific CD4+ T-cells detected by MHC class II tetramers in peripheral blood of type 1 diabetes patients and at-risk subjects.
    Oling V; Marttila J; Ilonen J; Kwok WW; Nepom G; Knip M; Simell O; Reijonen H
    J Autoimmun; 2005 Nov; 25(3):235-43. PubMed ID: 16263242
    [TBL] [Abstract][Full Text] [Related]  

  • 9. On the pathogenicity of autoantigen-specific T-cell receptors.
    Burton AR; Vincent E; Arnold PY; Lennon GP; Smeltzer M; Li CS; Haskins K; Hutton J; Tisch RM; Sercarz EE; Santamaria P; Workman CJ; Vignali DA
    Diabetes; 2008 May; 57(5):1321-30. PubMed ID: 18299317
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protective regulatory T cell generation in autoimmune diabetes by DNA covaccination with islet antigens and a selective CTLA-4 ligand.
    Glinka Y; Chang Y; Prud'homme GJ
    Mol Ther; 2006 Oct; 14(4):578-87. PubMed ID: 16790365
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Persistent T cell anergy in human type 1 diabetes.
    Dosch H; Cheung RK; Karges W; Pietropaolo M; Becker DJ
    J Immunol; 1999 Dec; 163(12):6933-40. PubMed ID: 10586096
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification and monitoring of effector and regulatory T cells during experimental arthritis based on differential expression of CD25 and CD134.
    Nolte-'t Hoen EN; Boot EP; Wagenaar-Hilbers JP; van Bilsen JH; Arkesteijn GJ; Storm G; Everse LA; van Eden W; Wauben MH
    J Leukoc Biol; 2008 Jan; 83(1):112-21. PubMed ID: 17928458
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Soluble, dimeric HLA DR4-peptide chimeras: an approach for detection and immunoregulation of human type-1 diabetes.
    Preda I; McEvoy RC; Lin M; Bona CA; Rapaport R; Brumeanu TD; Casares S
    Eur J Immunol; 2005 Sep; 35(9):2762-75. PubMed ID: 16106371
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Robust B cell immunity but impaired T cell proliferation in the absence of CD134 (OX40).
    Pippig SD; Peña-Rossi C; Long J; Godfrey WR; Fowell DJ; Reiner SL; Birkeland ML; Locksley RM; Barclay AN; Killeen N
    J Immunol; 1999 Dec; 163(12):6520-9. PubMed ID: 10586044
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The activation profile of tumour-associated reactive T-cells differs in the nodular and diffuse patterns of lymphocyte predominant Hodgkin's disease.
    Lin P; Medeiros LJ; Wilder RB; Abruzzo LV; Manning JT; Jones D
    Histopathology; 2004 Jun; 44(6):561-9. PubMed ID: 15186271
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autoreactive T cells in endocrine/organ-specific autoimmunity: why has progress been so slow?
    Roep BO
    Springer Semin Immunopathol; 2002 Dec; 24(3):261-71. PubMed ID: 12503054
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin-7 is a survival factor for CD4+ CD25+ T-cells and is expressed by diabetes-suppressive dendritic cells.
    Harnaha J; Machen J; Wright M; Lakomy R; Styche A; Trucco M; Makaroun S; Giannoukakis N
    Diabetes; 2006 Jan; 55(1):158-70. PubMed ID: 16380489
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional characterization of OX40 expressed on human CD8+ T cells.
    Fujita T; Ukyo N; Hori T; Uchiyama T
    Immunol Lett; 2006 Jul; 106(1):27-33. PubMed ID: 16750861
    [TBL] [Abstract][Full Text] [Related]  

  • 19. No alterations in the frequency of FOXP3+ regulatory T-cells in type 1 diabetes.
    Brusko T; Wasserfall C; McGrail K; Schatz R; Viener HL; Schatz D; Haller M; Rockell J; Gottlieb P; Clare-Salzler M; Atkinson M
    Diabetes; 2007 Mar; 56(3):604-12. PubMed ID: 17327427
    [TBL] [Abstract][Full Text] [Related]  

  • 20. T cells to a dominant epitope of GAD65 express a public CDR3 motif.
    Quinn A; McInerney M; Huffman D; McInerney B; Mayo S; Haskins K; Sercarz E
    Int Immunol; 2006 Jun; 18(6):967-79. PubMed ID: 16641112
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.